Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Newborn Jaundice Treatment Market Growth From $2.84 Billion In 2026 To $3.49 Billion By 2030 At A CAGR Of 5.3%
The newborn jaundice treatment market size has experienced robust expansion over recent years. This market is projected to expand from $2.71 billion in 2025 to $2.84 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.0%. Factors contributing to this historical growth include the widespread occurrence of neonatal jaundice worldwide, restricted access to sophisticated phototherapy equipment in resource-constrained environments, dependence on traditional fluorescent lamp-based treatment methods, belated identification of hyperbilirubinemia in infants, and the absence of uniform neonatal screening guidelines.
The newborn jaundice treatment market is projected for significant expansion over the coming years, reaching $3.49 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.3%. Factors contributing to this growth during the forecast period include the increasing adoption of LED-based phototherapy systems, a heightened emphasis on early neonatal screening initiatives, a rising need for home-based newborn care solutions, innovations in non-invasive bilirubin monitoring technologies, and the worldwide expansion of neonatal intensive care infrastructure. Key developments anticipated in the forecast period involve LED-based intensive phototherapy systems designed for fast bilirubin reduction in neonates, fiber-optic blanket phototherapy that allows continuous treatment with minimal disturbance to infants, intelligent bilirubin monitoring systems capable of real-time phototherapy adjustments, portable homecare phototherapy devices facilitating earlier hospital discharge, and dual-surface phototherapy units improving treatment efficiency within neonatal intensive care settings.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample_request?id=62804545&type=smp
Newborn Jaundice Treatment Market Growth Factors Supporting Long-Term Expansion
The rising birth rates are anticipated to propel the growth of the newborn jaundice treatment market going forward. Birth rates indicate the number of live births within a specific population over a given period, reflecting overall population expansion and reproductive trends. The increase in birth rates is driven by enhanced access to maternal healthcare, population growth, and supportive government policies in certain regions, resulting in a higher count of newborns requiring postnatal care. Newborn jaundice treatment supports this trend by facilitating early diagnosis and effective management of bilirubin levels in a growing neonatal population through phototherapy and related interventions, thereby reducing the risk of complications. For instance, in July 2025, according to the Office for National Statistics, a UK-based government department, there were 594,677 live births in England and Wales in 2024, an increase of 3,605 (0.6%) compared to 2023, marking the first rise since 2021. Therefore, increasing birth rates are a key driver for the growth of the newborn jaundice treatment market.
Newborn Jaundice Treatment Market Segments: Where Are The Largest Growth Opportunities?
The newborn jaundice treatment market covered in this report is segmented –
1) By Device Type: Overhead Phototherapy Units, Portable Phototherapy Units, Other Device Types
2) By Modality: Conventional Phototherapy, Light Emitting Diode Phototherapy, Fiber Optic Phototherapy
3) By Service Type: Diagnostic And Screening Services, Therapeutic And Nursing Services, Support And Monitoring Services
4) By Technology: Light Emitting Diode Light Sources, Fluorescent, Halogen, Fiberoptic
5) By End User: Hospitals, Neonatal Intensive Care Units, Pediatric Clinics, Homecare Settings
Subsegments:
1) By Overhead Phototherapy Units: Light Emitting Diode Overhead Phototherapy Units, Fluorescent Lamp Overhead Phototherapy Units, Halogen Lamp Overhead Phototherapy Units, Double Surface Overhead Phototherapy Units
2) By Portable Phototherapy Units: Wearable Phototherapy Blanket Units, Fiber Optic Phototherapy Pad Units, Portable Light Emitting Diode Phototherapy Units, Compact Handheld Phototherapy Units
3) By Other Device Types: Phototherapy Bassinet Systems, Phototherapy Incubator Integrated Systems, Combination Phototherapy And Warming Units, Multisurface Phototherapy Systems
Newborn Jaundice Treatment Market Industry Trends Shaping Future Revenue Growth
Major companies engaged in the newborn jaundice treatment market are prioritizing sophisticated non-invasive screening technologies, such as smartphone-based bilirubin detection methods, to enable prompt diagnosis and improve care accessibility. This smartphone-driven bilirubin detection process uses mobile imaging and algorithm-based skin coloration analysis to estimate bilirubin levels, thereby removing the need for blood sampling or specialized equipment. As an illustration, in July 2024, Konica Minolta, a technology company based in Japan, partnered with Picterus AS, a digital health company from Norway, to enhance non-invasive jaundice screening solutions. This partnership utilizes smartphone-based imaging to facilitate early detection, increase accessibility in underserved settings, and support timely intervention while maintaining high screening accuracy. Additionally, this solution lessens dependency on hospital-based diagnostic instruments and allows for point-of-care screening in both community and home environments. It also supports scalable neonatal screening initiatives by providing healthcare providers with cost-effective and user-friendly technology.
Newborn Jaundice Treatment Market Major Participants And Competitive Dynamics
Major companies operating in the newborn jaundice treatment market are Koninklijke Philips N. V., GE HealthCare Technologies, Drägerwerk AG & Co. KGaA, Heal Force Bio-Meditech Holdings Limited, Atom Medical, Ningbo David Medical Device, Fanem Ltd., MTTS Inc., Phoenix Medical Systems, Olidef Medical, Dixion Vertrieb Medizinischer Geräte GmbH, Anandic Medical Systems AG, Weyer GmbH, AVI Healthcare Pvt. Ltd., Nice Neotech, Natus Medical, Ibis Medical, Novos Medical Systems, GINEVRI Srl, Solarc Systems Inc., Cobams Srl, Kay & Company, Nareena Lifesciences Private Limited, Alfamedic, Delta
Access The Complete Newborn Jaundice Treatment Market Report:
https://www.thebusinessresearchcompany.com/report/newborn-jaundice-treatment-market-report
Newborn Jaundice Treatment Market Geographic Distribution And Regional Opportunities
North America was the largest region in the newborn jaundice treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the newborn jaundice treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.